Raymond James Financial Services Advisors, Inc. Gamida Cell Ltd. Transaction History
Raymond James Financial Services Advisors, Inc.
- $66.3 Billion
- Q1 2024
A detailed history of Raymond James Financial Services Advisors, Inc. transactions in Gamida Cell Ltd. stock. As of the latest transaction made, Raymond James Financial Services Advisors, Inc. holds 20,204 shares of GMDA stock, worth $606. This represents 0.0% of its overall portfolio holdings.
Number of Shares
20,204
Previous 16,204
24.69%
Holding current value
$606
Previous $6,000
100.0%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding GMDA
# of Institutions
58Shares Held
11.4MCall Options Held
235KPut Options Held
70.5K-
Levin Capital Strategies, L.P. New York, NY3.75MShares$112,4280.01% of portfolio
-
Meitav Dash Investments LTD3.24MShares$97,1260.0% of portfolio
-
Nantahala Capital Management, LLC New Canaan, CT800KShares$24,0000.0% of portfolio
-
Stone X Group Inc.794KShares$23,8180.0% of portfolio
-
Qube Research & Technologies LTD London, X0298KShares$8,9340.0% of portfolio
About Gamida Cell Ltd.
- Ticker GMDA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 76,319,600
- Market Cap $2.29M
- Description
- Gamida Cell Ltd., a clinical-stage biopharmaceutical company, develops cell therapies to cure blood cancers and serious hematologic diseases. The company's lead product candidate is omidubicel, a cell therapy that has completed Phase III clinical trial in patients with high-risk hematologic malignancies, as well as in Phase I/II clinical trials ...